arteriosclerosis/triglyceride

TECHNICAL FIELD The present invention relates to a novel peptide inhibiting elevations of triglyceride levels in blood; an agent for inhibiting elevations of triglyceride levels in blood comprising the peptide as an active component; a food for specified health use (the so-called physiologically

TECHNICAL FIELD The present invention relates to a novel peptide inhibiting elevations of triglyceride levels in blood; an agent for inhibiting elevations of triglyceride levels in blood comprising the peptide as an active component; a food for specified health use (the so-called physiologically

BACKGROUND OF THE INVENTION The present invention relates to a pyrrolealdehyde derivative which has an excellent activity of reducing lipids and, therefore, useful as a therapeutical medicine for hyperlipemia. Heretofore, it has been considered that a metabolic disorder of lipids such as

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a useful lipid metabolism improving composition. More particularly, the invention relates to a useful lipid metabolism improving composition comprising S-(.alpha., .beta.-dicarboxyethyl)glutathione, which is a

CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority to PCT Patent Application No. PCT/EP02/03540 filed Mar. 28, 2002 and European Patent Applications No. EP01 108 315.1 filed Apr. 2, 2001 and EP01 113 419.4 filed Jun. 1, 2001. DESCRIPTION This invention relates to the use of

DESCRIPTION This invention relates to the use of nucleic acid and amino acid sequences of protein disulfide isomerase and ABC transporter homologous proteins, and to the use of these sequences in the diagnosis, study, prevention, and treatment of diseases and disorders related to body-weight

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to a useful lipid metabolism improving medicinal composition. More particularly, this invention relates to a useful lipid metabolism improving medicinal composition containing an ascorbyl tocopheryl phosphate compound or a

The present invention relates to azolopyridin-2-one derivatives of the general formula I, to their pharmaceutically useful salts and to their use as medicinal substances. Compounds of similar structure are known from EP 1275653. However, these are used as fungicides. Compounds having an inhibitory

FIELD OF THE INVENTION This invention relates to pyrrolecarboxylic acid derivatives or pharmaceutically acceptable salts thereof which are potent in reducing lipids and, therefore, useful as a therapeutical medicine for hyperlipemia. BACKGROUND OF THE INVENTION Heretofore, it has been considered

TECHNICAL FIELD The present invention is related to novel heterocyclic compounds and pharmaceutically acceptable salts thereof. The compounds of the present invention have blood triglyceride lowering effect, low-density lipoprotein cholesterol (hereinafter, referred to as "LDL-C") lowering effect,

TECHNICAL FIELD The present invention is related to novel heterocyclic compounds and pharmaceutically acceptable salts thereof. The compounds of the present invention have blood triglyceride lowering effect, low-density lipoprotein cholesterol (hereinafter, referred to as "LDL-C") lowering effect,

TECHNICAL FIELD The present invention is related to novel heterocyclic compounds and pharmaceutically acceptable salts thereof. The compounds of the present invention have blood triglyceride lowering effect, low-density lipoprotein cholesterol (hereinafter, referred to as "LDL-C") lowering effect,

TECHNICAL FIELD The present invention is related to novel heterocyclic compounds and pharmaceutically acceptable salts thereof. The compounds of the present invention have blood triglyceride lowering effect, low-density lipoprotein cholesterol (hereinafter, referred to as "LDL-C") lowering effect,

FIELD OF THE INVENTION The present invention relates to soy protein, phytoestrogens and dietary fibres and compositions thereof suitable for preventing, alleviating and/or treating cardiovascular diseases such as arteriosclerosis, hypercholesterolemia, hyperlipidemia, hypertriglyceridemia,

TECHNICAL FIELD The present invention relates to a composition for preventing or treating hyperlipidemia, fatty liver disease or arteriosclerosis, which comprises an oxyntomodulin derivative as an active ingredient, and to a method for treating hyperlipidemia, fatty liver disease or arteriosclerosis